Skip to main content

Table 2 Follow-up data (FU)

From: Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: a midterm follow-up study

FU

Non-PICM

PICM

p value

SR

13.2%

18.2%

0.64

DR

86.8%

81.8%

0.65

LVEF-FU (%± SD)

65 (± 8.5)

38 (± 4.6)

0.01

ΔLVEF

2.3 (± 9.9)

20.4 (± 7.9)

< 0.0001

RV-PACE%

50 (± 40)

70 (± 30)

0.10

ACEI

56.6%

54.5%

0.84

ARB

30.2%

36.4%

0.74

MRA

75%

25%

0.03

BB

76.1%

81.8%

0.5

CCB

27.7%

9.1%

0.29

Digitoxin

5%

9.1%

0.46

  1. SR single-chamber pacemaker, DR double-chamber pacemaker, medication: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, MRA mineralocorticoid receptor antagonist, BB beta-blocker, CCB calcium canal blocker